These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
724 related articles for article (PubMed ID: 30114351)
1. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity. Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351 [TBL] [Abstract][Full Text] [Related]
2. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies. Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239 [TBL] [Abstract][Full Text] [Related]
3. A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity. Li L; Guo J; Wang Y; Xiong X; Tao H; Li J; Jia Y; Hu H; Zhang J Adv Sci (Weinh); 2018 Oct; 5(10):1800781. PubMed ID: 30356945 [TBL] [Abstract][Full Text] [Related]
4. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis. Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary circulation-mediated heart targeting for the prevention of heart failure by inhalation of intrinsically bioactive nanoparticles. Liu C; Chen L; Ma Y; Hu K; Wu P; Pan L; Chen H; Li L; Hu H; Zhang J Theranostics; 2021; 11(17):8550-8569. PubMed ID: 34373758 [TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin. Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987 [TBL] [Abstract][Full Text] [Related]
7. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases. Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099 [TBL] [Abstract][Full Text] [Related]
8. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680 [TBL] [Abstract][Full Text] [Related]
9. Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis. Wang C; Zhao R; Wang Z; Xu T; Huang P RSC Adv; 2023 May; 13(24):16211-16221. PubMed ID: 37266511 [TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640 [TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis. Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness. Yu EPK; Reinhold J; Yu H; Starks L; Uryga AK; Foote K; Finigan A; Figg N; Pung YF; Logan A; Murphy MP; Bennett M Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2322-2332. PubMed ID: 28970293 [TBL] [Abstract][Full Text] [Related]
13. β-Cyclodextrin and Hyaluronic Acid-Modified Targeted Nanodelivery System for Atherosclerosis Prevention. Yu J; Ma Y; Zhang X; Wang S; Zhou L; Liu X; Li L; Liu L; Song H; Luo Y; Wen S; Li W; Niu X ACS Appl Mater Interfaces; 2024 Jul; 16(27):35421-35437. PubMed ID: 38940349 [TBL] [Abstract][Full Text] [Related]
14. PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice. Wu Y; Xie G; Xu Y; Ma L; Tong C; Fan D; Du F; Yu H J Transl Med; 2015 Sep; 13():316. PubMed ID: 26410585 [TBL] [Abstract][Full Text] [Related]
15. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation. Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325 [TBL] [Abstract][Full Text] [Related]
16. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE Yan J; Li M; Wang XD; Lu ZY; Ni XL Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379 [TBL] [Abstract][Full Text] [Related]
17. D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation. Menini S; Iacobini C; Ricci C; Scipioni A; Blasetti Fantauzzi C; Giaccari A; Salomone E; Canevotti R; Lapolla A; Orioli M; Aldini G; Pugliese G Br J Pharmacol; 2012 Jun; 166(4):1344-56. PubMed ID: 22229552 [TBL] [Abstract][Full Text] [Related]
18. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice. Dou Y; Guo J; Chen Y; Han S; Xu X; Shi Q; Jia Y; Liu Y; Deng Y; Wang R; Li X; Zhang J J Control Release; 2016 Aug; 235():48-62. PubMed ID: 27235978 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Characterization of Fucoidan-Chitosan Nanoparticles Targeting P-Selectin for Effective Atherosclerosis Therapy. Liu M; Zhang Y; Ma X; Zhang B; Huang Y; Zhao J; Wang S; Li Y; Zhu Y; Xiong J; He T; Wang Y; Han W; Yang K; Bi X; Liu Y; Zhang H Oxid Med Cell Longev; 2022; 2022():8006642. PubMed ID: 36120595 [TBL] [Abstract][Full Text] [Related]
20. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]